SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing presentation: reset
Efficacy, Safety, and Immunogenicity of H56:IC31 Vaccine for Prevention of Recurrent TB
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
Efficacy, Safety, and Immunogenicity of H56:IC31 Vaccine for Prevention of Recurrent TB (ABSTRACT
210)
Alvaro Borges
Statens Serum Institut
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
1 of
1
|
